Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atea Pharmaceuticals, Inc.

2.85
-0.1400-4.68%
Post-market: 2.850.00000.00%16:10 EDT
Volume:347.98K
Turnover:999.63K
Market Cap:243.75M
PE:-1.43
High:2.98
Open:2.96
Low:2.81
Close:2.99
Loading ...
Jun 21, 2024

Major Issues Report

Form 8-K - Current report
Jun 20, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 14, 2024

Major Issues Report

Form 8-K - Current report
Feb 29, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 28, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 07, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Feb 07, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 02, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities